Finance
Morning Bid: Investors itching for progress in US-China talks
Published by Global Banking & Finance Review®
Posted on June 10, 2025
3 min readLast updated: January 23, 2026
Global Banking & Finance Review®
Company
Published by Global Banking & Finance Review®
Posted on June 10, 2025
3 min readLast updated: January 23, 2026
Investors are watching US-China trade talks closely, with markets reacting to potential progress. Stocks rise as Trump reports positive feedback.
A look at the day ahead in European and global markets from Johann M Cherian
With precious little to report out of Sino-U.S. trade talks in London, investors are ready to pounce on almost any sign a thaw in the frigid relationship between the two superpowers is just around the corner.
Stocks in Asia are creeping higher, as are U.S. and European equity futures, while the dollar was also a tad firmer after President Donald Trump said he was getting "good reports" from Monday's meeting with China.
Talks resume at 0900 GMT on Tuesday at Lancaster House and markets want a deal to flesh out details around U.S. tech export controls and those around Chinese rare earths, and of course, where the final average rate of tariffs will settle.
Recent data indicates the trade war is taking a toll on both major economies, which could soon rattle other major economies.
Global investors are also in the market for fresh trade deals, with about a month left before Trump's tariff pause expires.
Also expected out of the UK will be an employment report with investors and the Bank of England keen on how pay growth - a reflection of broader price pressures - fared in April.
Signs of cooling wage growth could be a relief for BoE policymakers who are currently divided on the approach to further monetary policy easing.
Meanwhile, the global healthcare sector was caught in the crossfire as vaccine sceptic U.S. Health Secretary Robert F. Kennedy Jr. fired all members of a U.S. Centers for Disease Control and Prevention panel of vaccine experts.
The move could be a headache for companies such as GSK, Sanofi, AstraZeneca, Moderna and BioNTech as they face longer waits for vaccine approvals.
Advertising firms weren't spared from scrutiny either as the Wall Street Journal reported that the U.S. Federal Trade Commission has sought information from some of the industry's leading firms.
Omnicom, WPP, Dentsu, Interpublic Group and Publicis Groupe were among those asked by the watchdog on whether advertising and advocacy groups violated antitrust laws by coordinating boycotts of certain sites.
Key developments that could influence markets on Tuesday:
- UK May BRC retail sales
- UK April employment data
- U.S. 3-year Treasury note auction
- Reserve Bank of Australia Governance Board meeting
Trying to keep up with the latest tariff news?
Our new daily news digest offers a rundown of the top market-moving headlines impacting global trade. Sign up for Tariff Watch here.
(Editing by Sam Holmes)
Investors are eager for any signs of progress or a thaw in the relationship between the US and China, particularly regarding tech export controls and rare earths.
Recent data suggests that the trade war is impacting both the US and Chinese economies, which could lead to repercussions for other major economies.
An employment report is expected from the UK, which will provide insights into pay growth and broader price pressures, crucial for the Bank of England's monetary policy decisions.
Key developments include the UK May BRC retail sales, UK April employment data, a U.S. Treasury note auction, and a Reserve Bank of Australia Governance Board meeting.
U.S. Health Secretary Robert F. Kennedy Jr. has dismissed all members of the CDC, which could delay vaccine approvals for companies like GSK, Sanofi, and Moderna.
Explore more articles in the Finance category
